The results suggest that improvements in CEC, through improvement in adipose tissue health in terms of adipokine secretion and insulin sensitivity could be an important pathway in modulating obesity-related CVD risk. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.